Skip to content

Xylem

NYSE: XYL · USD

Xylem (XYL) Economic Moat Analysis—

Avantages concurrentiels, preuves datées et risques d’érosion.

Incertain avantage concurrentiel

Xylem has an installed base supporting parts, replacement and service demand, tailored operating services, and demonstrated price realization. These establish a current aftermarket position and potential switching costs, but do not establish costly customer replacement, protected aftermarket access or durable superiority over competitors. Pricing contributed positively in 2025 and second-quarter 2026 but lagged inflation in the consolidated gross-margin bridges; productivity supported resilience. Insufficient evidence of durable barriers, rather than demonstrated competitive weakness, supports an uncertain moat verdict.

Switching costs

The installed base generates aftermarket demand, while tailored lifecycle services and outsourced operations create potential customer integration. The passages establish these activities but do not demonstrate material switching costs.

Durabilité
Installed-base demand is described in both the 2023 and 2025 filings. Its persistence supports an ongoing aftermarket position, but exclusive servicing rights, replacement friction and customer-level renewal outcomes remain undisclosed.
Concurrents
Comparaison non établie
Risques d’érosion
Customers can reschedule or cancel annual and multiyear contracts. Technology, pricing and procurement pressures could weaken differentiation; these are disclosed possibilities, not proof of realized erosion. Some segment backlogs declined despite consolidated backlog growth.
Ce qui invaliderait la thèse
The switching-cost hypothesis would be invalidated by evidence that customers routinely replace Xylem systems or service providers without meaningful conversion costs or disruption. Sustained loss of installed-base service demand or contract renewals would weaken the current aftermarket position.
Preuves (4) · Contre-preuves (4)

Évolution depuis la dernière analyse

  • The uncertain moat verdict is unchanged after re-examining the supplied catalog; all four moat criteria remain null because durable structural protection is unestablished.
  • The eight previously assessed pricing and management grades remain supported by current catalog passages, with fresh evidence references rather than inherited citations.
  • The review explicitly weighs the reduction in July 2026 revenue guidance against demonstrated operating improvement; guidance remains a forecast, not a realized result.

Limites de l’analyse

  • The supplied competitive disclosures identify generic competitor categories rather than named product-market rivals. Compensation peers, acquired companies and former employers are not established competitors, so the competitor array is empty.
  • Installed-base revenue and tailored services support current customer relationships, but switching costs, exclusive aftermarket access, renewal rates, market-share persistence and comparative product economics are not quantified.
  • Pricing bridges demonstrate realized pricing contributions, not pure list-price increases, price elasticity or unrestricted repricing of existing contracts.
  • Most operating and strategic disclosures are issuer supplied. Reported results and contractual terms support numerical grades, but brand leadership, differentiation and early synergy delivery are not independently corroborated here.
  • Executive grants and compensation restrictions are disclosed; individual executive ownership levels, ownership-guideline compliance and performance-target rigor remain missing.
  • All supplied source dates have dateKind filed. Assessment uses each disclosure's reporting period and filing date; no retrieval date is treated as publication evidence.

Indicateurs financiers à confronter à la thèse

Ratios calculés à partir des publications annuelles. Une valeur manquante reste indisponible. Les graphiques détaillés sont accessibles dans les autres onglets.

Indicateurs financiers à confronter à la thèse
PériodeGross marginOperating marginROICFCF margin
202138.0%11.3%11.5%6.4%
202237.7%11.3%11.5%7.0%
202336.9%8.9%7.9%7.7%
202437.5%11.8%7.2%11.0%
202538.5%13.5%8.4%10.1%

Pouvoir de fixation des prix63

  • Pricing outcomes

    Reported price realization contributed to growth in 2023 and 2024, and added 140 basis points to consolidated gross margin in 2025 and 180 basis points in second-quarter 2026. These demonstrate repeated pricing outcomes, although the latest consolidated contributions lagged inflation.

  • Customer demand

    Assessed indirectly from installed-base parts and service demand, $5.315 billion of June 2026 backlog and no significant quarterly cancellations. A significant new contract contributed to backlog growth, so it is not a customer-retention measure. Cancellation rights and segment backlog declines temper the evidence.

  • Margin resilience

    First-half 2026 gross margin increased 160 basis points. Disclosed productivity savings supported expansion despite inflation exceeding pricing contributions in both the 2025 and second-quarter 2026 consolidated bridges. Tariff recoveries also reduced costs; resilience is demonstrated but is not attributable solely to pricing.

  • Pricing freedom

    Realized pricing demonstrates practical ability to obtain higher prices on some business. Customer cancellation and rescheduling rights, variable consideration and required performance guarantees constrain terms. Existing-contract repricing rights and escalation provisions are undisclosed.

Management69

  • Capital discipline

    First-half operating cash flow increased to $398 million against $179 million of capital expenditure. However, $1.243 billion of cash repurchases and $207 million of dividends accompanied $990 million of net long-term debt issuance. Reported early synergy delivery is favorable; the $37 million cumulative metering disposal loss is adverse. Acquisition returns and repurchase value creation remain unproven.

  • Incentive alignment

    Actual CEO equity grants, three-year performance-share vesting, financial and relative-return targets, and prohibitions on hedging, pledging and shorting establish substantive alignment mechanisms. These are actual disclosures rather than proposed awards. Executive ownership levels, target rigor and the effects of adjusted metrics remain limitations.

  • Execution

    Higher first-half operating income and operating cash flow, together with reported productivity savings, demonstrate execution through indirect operating evidence. The issuer reports reaching the $140 million Evoqua synergy run rate one year early. Disposal losses, uneven segment backlog and reduced revenue growth guidance temper the assessment; the revised forecast is not a realized failure.

  • Governance

    An independent chair, 89% independent board, fully independent committees, annual director elections, shareholder meeting rights and no poison pill support strong governance. The auditor's effective-controls opinion adds demonstrated reporting oversight. These disclosures do not establish exceptional long-term governance outcomes.

Sources et méthode

Publication courante · Mis à jour 19/10/2026 · Version 5

Interprétation IA fondée sur des extraits vérifiés. Les déclarations de l’entreprise et les limites de couverture restent explicites.

Méthode quality-scores-2 : six catégories de même poids. Le score global exige une couverture complète. Les données manquantes ne valent pas zéro. Les évaluations qualitatives sont des interprétations sourcées, pas des probabilités. 5/6 · 19/10/2026

Moat—

Insufficient evidence for every rubric criterion; no category score is inferred.

structural advantage · — · Installed-base demand and tailored operating services establish a business position, but do not establish protected aftermarket access, material switching costs or a durable comparative advantage.

durability · — · Installed-base revenue is described across multiple reporting years, but persistence of activity does not establish durability of competitive protection.

customer dependency · — · Outsourced operations and lifecycle services may embed Xylem in customer processes. The passages do not demonstrate the cost or disruption of changing suppliers, and contracts permit cancellation or rescheduling.

erosion resilience · — · Positive pricing and productivity show operating resilience, but cannot establish resilience of an unidentified structural barrier. Competitive and technology risks are possibilities rather than realized moat erosion.

Pouvoir de fixation des prix63

Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.

realized pricing · 3/4 · Reported price realization contributed to growth in 2023 and 2024, and added 140 basis points to consolidated gross margin in 2025 and 180 basis points in second-quarter 2026. These demonstrate repeated pricing outcomes, although the latest consolidated contributions lagged inflation.

retention · 2/4 · Assessed indirectly from installed-base parts and service demand, $5.315 billion of June 2026 backlog and no significant quarterly cancellations. A significant new contract contributed to backlog growth, so it is not a customer-retention measure. Cancellation rights and segment backlog declines temper the evidence.

margin resilience · 3/4 · First-half 2026 gross margin increased 160 basis points. Disclosed productivity savings supported expansion despite inflation exceeding pricing contributions in both the 2025 and second-quarter 2026 consolidated bridges. Tariff recoveries also reduced costs; resilience is demonstrated but is not attributable solely to pricing.

contractual freedom · 2/4 · Realized pricing demonstrates practical ability to obtain higher prices on some business. Customer cancellation and rescheduling rights, variable consideration and required performance guarantees constrain terms. Existing-contract repricing rights and escalation provisions are undisclosed.

Prévisibilité96

Five consecutive annual periods. Equal weights: nondeclining revenue frequency; revenue-growth volatility (5–40pp); positive FCF frequency; FCF-margin volatility (3–20pp). Stability indicator, not a growth forecast.

Nondeclining revenue years (%)
100.00
Revenue growth volatility (pp)
11.22
Positive FCF years (%)
100.00
FCF margin volatility (pp)
1.80

Solidité financière87

Equal-weight grades: debt/FCF (1–8x), net debt/earnings before interest and tax (0–5x), interest service (1–12x), current ratio (0.75–2x). Earnings use reported operating income, or reported pretax profit plus reported interest expense when operating income is unavailable. Interest service uses earnings/interest expense; if unavailable, it uses reported operating cash flow/cash interest paid, without relabeling cash paid as accrued expense. Nonpositive cash flow/earnings score 0 for their service component; reported zero interest with a positive numerator scores 100. Net cash scores 100 for net leverage. Missing disclosures remain unavailable. General nonfinancial-company rubric, not a credit rating; exceptional and nonoperating gains are not normalized out. IFRS finance-cost and cash-flow classifications retain their reported scope.

debtFcfGrade
83.80
netDebtEbitGrade
92.43
interestCoverageGrade
100.00
currentRatioGrade
70.00
Debt / FCF (x)
2.13
Net debt / operating income (x)
0.38
Interest coverage (x)
42.17
Current ratio (x)
1.63

Allocation du capital59

Three-year equal-weight indicators: pretax return on average invested capital (0–25%; equity + debt − cash, each year and its prior year), share-count growth (0–5%, lower better), share-based cost/revenue (2–20%, lower better), consolidated FCF/net income (0–1x). Return uses reported operating income or, if unavailable, EBIT calculated from reported pretax profit plus reported interest expense; exceptional/nonoperating gains are not normalized out. Share-based cost uses the reported cash-flow add-back or, if absent, separately reported recognized compensation expense; the latter never becomes an FCF adjustment. Nonpositive net income scores 0 for cash conversion; absent income/FCF stays unavailable. Nonpositive invested capital has no defined return and remains unavailable. Does not establish acquisition quality or buyback timing.

3-year pre-tax operating return (%)
9.13
3-year average dilution (%)
10.84
3-year average SBC / revenue (%)
0.69
cashConversionGrade
98.45

Qualité du management69

Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.

capital discipline · 2/4 · First-half operating cash flow increased to $398 million against $179 million of capital expenditure. However, $1.243 billion of cash repurchases and $207 million of dividends accompanied $990 million of net long-term debt issuance. Reported early synergy delivery is favorable; the $37 million cumulative metering disposal loss is adverse. Acquisition returns and repurchase value creation remain unproven.

incentive alignment · 3/4 · Actual CEO equity grants, three-year performance-share vesting, financial and relative-return targets, and prohibitions on hedging, pledging and shorting establish substantive alignment mechanisms. These are actual disclosures rather than proposed awards. Executive ownership levels, target rigor and the effects of adjusted metrics remain limitations.

execution · 3/4 · Higher first-half operating income and operating cash flow, together with reported productivity savings, demonstrate execution through indirect operating evidence. The issuer reports reaching the $140 million Evoqua synergy run rate one year early. Disposal losses, uneven segment backlog and reduced revenue growth guidance temper the assessment; the revised forecast is not a realized failure.

governance · 3/4 · An independent chair, 89% independent board, fully independent committees, annual director elections, shareholder meeting rights and no poison pill support strong governance. The auditor's effective-controls opinion adds demonstrated reporting oversight. These disclosures do not establish exceptional long-term governance outcomes.

Preuves

•A substantial global installed base of products and solutions across the water cycle that provides for steady parts, replacement and service revenue

Business overview / installed base and aftermarket revenue · Dépôt 25/02/2026

•A substantial global installed base across the water cycle that provides for steady recurring and replacement revenue

2023 business overview / installed-base recurring and replacement revenue · Dépôt 28/02/2024

The Water Solutions and Services segment provides tailored services and solutions, in collaboration with customers and backed by life‑cycle services, including on‑demand water, outsourced water, recycle/reuse, specialty dewatering and emergency response service alternatives to improve operational reliability, performance and environmental compliance.

Segment disclosures / tailored lifecycle services · Dépôt 25/02/2026

Key offerings within this segment also include equipment systems for industrial needs (influent water, boiler feed water, ultrahigh purity, process water, wastewater treatment, and recycle/reuse), full-scale outsourcing of operations and maintenance, and municipal services, including odor and corrosion control services, as well as leak detection, condition assessment and asset management and pressure monitoring solutions.

Segment disclosures / equipment systems and outsourced operations · Dépôt 25/02/2026

Annual or multi-year contracts are subject to rescheduling and cancellation by customers due to the long-term nature of the contracts.

MD&A / backlog cancellation and rescheduling rights · Dépôt 28/07/2026

Our competitive position and future growth depend on a number of factors, including our ability to: (i) enhance and differentiate our offerings, business models and customer experience through efficiency, security, and the addition of innovative features or technologies, such as AI, that address emerging regulations and trends, meet customers’ needs, and prevent commoditization; (ii) defend our market share against an ever-expanding number of competitors, including new or non-traditional competitors from outside our industry, such as large technology firms; (iii) invest in and maintain our network of channel partners; (iv) attract, develop, retain and train talent with commercial, innovation, digital and technical expertise, and understanding of customers’ needs to develop and commercialize new technologies; (v) leverage and expand our ecosystem of innovation partners, including universities, venture capital, start-ups, and other technology innovators; (vi) invest in manufacturing, research and development, engineering, sales, marketing, systems modernization, AI, and digitization of customer solution and support tools; (vii) win and execute large contracts on schedule and on budget; and (viii) optimize our supply chain and manufacturing to enable predictable and efficient delivery to customers, and to compete for business subject to procurement laws, regulations and government policies, and regulations governing sustainability and domestic content in various jurisdictions.

Risk factors / differentiation, competition and required investment · Dépôt 25/02/2026

Pricing pressures, tariffs, procurement policies, and disruptive or emerging technologies, such as AI, may require price adjustments or rationalization of certain of our offerings and affect our profitability.

Risk factors / pricing, procurement and technology pressure · Dépôt 25/02/2026

The backlog increase was partially offset by backlog declines in the Measurement and Control Solutions and Water Infrastructure segments primarily due to revenue outpacing orders and contract wins.

MD&A / segment backlog declines · Dépôt 28/07/2026

The gross margin increase for the year included favorable operational impacts of 370 basis points, consisting of 230 basis points of productivity savings and 140 basis points of price realization.

2025 consolidated gross-margin bridge / productivity and price realization · Dépôt 25/02/2026

These impacts were partially offset by 290 basis points of unfavorable operating impacts, driven by 190 basis points of inflation and 60 basis points of unfavorable mix.

2025 consolidated gross-margin bridge / inflation and mix · Dépôt 25/02/2026

Gross margin expansion included 550 basis points of favorable operational impacts, driven by 230 basis points of productivity savings, 180 basis points of price realization, and 80 basis points of favorable mix.

Second-quarter 2026 consolidated gross-margin bridge / productivity and pricing · Dépôt 28/07/2026

These increases in gross margin were partially offset by 380 basis points of unfavorable operational impacts driven by 240 basis points of inflation and 80 basis points of decreased volume.

Second-quarter 2026 consolidated gross-margin bridge / inflation and volume · Dépôt 28/07/2026

Gross margin as a percentage of revenue increased 160 basis points to 39.6% for the six months ended June 30, 2026, as compared to 38.0% for the six months ended June 30, 2025.

MD&A / first-half 2026 consolidated gross margin · Dépôt 28/07/2026

Total backlog was $5,315 million at June 30, 2026, an increase of $297 million, or 5.9%, as compared to June 30, 2025 backlog of $5,018 million.

MD&A / June 2026 backlog and year-over-year growth · Dépôt 28/07/2026

There were no significant order cancellations during the quarter.

MD&A / quarterly order cancellations · Dépôt 28/07/2026

The transaction price is adjusted for our estimate of variable consideration which may include a right of return, discounts, rebates, penalties, retainage, and warranties.

Revenue recognition / variable contractual consideration · Dépôt 25/02/2026

Many customers require performance guarantees for effluent produced by our water treatment equipment and services.

Risk factors / customer-required performance guarantees · Dépôt 25/02/2026

AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions) For the six months ended June 30, 2026 2025 Operating Activities Net income $ 450 $ 395 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation 130 137 Amortization 150 153 Share-based compensation 25 25 Restructuring and asset impairment charges 42 47 Loss from sale of businesses 12 10 Other, net (27) 6 Payments for restructuring (49) (36) Changes in assets and liabilities (net of acquisitions): Changes in receivables (142) (103) Changes in inventories (41) (27) Changes in accrued expenses (13) (64) Changes in accrued and deferred taxes 1 (50) Changes in long term receivables (104) (70) Other, net (36) (85) Net Cash – Operating activities 398 338 Investing Activities Capital expenditures (179) (169) Acquisitions of businesses, net of cash acquired (1) (7) Proceeds from sale of businesses, net of cash disposed 59 50 Proceeds from the sale of property, plant and equipment 11 5 Cash paid for investments (3) (3) Cash paid for asset acquisition (2) (37) Cash received from cross-currency swaps 17 21 Net Cash – Investing activities (98) (140) Financing Activities Short-term debt issued, net — 4 Long-term debt issued, net 990 — Long-term debt repaid (6) (28) Repurchase of common stock (1,243) (13) Proceeds from exercise of employee stock options 2 8 Dividends paid (207) (196) Other, net (20) (19) Net Cash – Financing activities (484) (244) Effect of exchange rate changes on cash (31) 84 Increase in cash classified within assets held for sale — 11 Decrease in cash classified within assets held for sale 12 — Changes in cash classified within assets held for sale 12 11 Net change in cash and cash equivalents (203) 49 Cash and cash equivalents at beginning of year 1,479 1,121 Cash and cash equivalents at end of period $ 1,276 $ 1,170 Supplemental disclosure of cash flow information: Cash paid during the period for: Interest $ 29 $ 32 Income taxes (net of refunds received) $ 157 $ 175 See accompanying notes to condensed consolidated financial statements.

First-half 2026 cash-flow statement / investment, distributions and financing · Dépôt 28/07/2026

As a result of the sale, the Company recognized a cumulative loss of $37 million, of which $23 million was recognized during the year ended December 31, 2025, and the remaining $14 million was recognized during 2026.

Acquisitions and divestitures / cumulative international metering disposal loss · Dépôt 28/07/2026

SPOTLIGHT: 2025 Performance Highlights ● Record orders over $8.9B (reported) supporting a $4.6B backlog ● Drove above market revenue growth and record adjusted EBITDA margin* through price and productivity ● Exited 2025 at full $140M Evoqua cost synergy run rate, 1 year ahead of our 3-year target ● Accelerated margin expansion through targeted efforts to simplify our businesses and take complexity out of our processes and structure, all to streamline our organization, strengthen our competitive positioning and enable us to better serve our customers ● Transformed our operating model, driving significant structural cost savings through simplification, 80/20 and strategic categorization of divisions ● Advanced our systems modernization journey to increase operational productivity, which will further bolster margin expansion and position us for more profitable growth · Returned $391M in capital to shareholders with our 2025 dividends · Advanced our high-impact culture ● Announced the signing of a definitive agreement to divest our international metering business, expected to close Q1 2026, to drive higher profitability and greater focus on our North America metering business ● Achieved an Injury Frequency rate of 0.43, a >17% improvement YOY ● Achieved the Carbon Disclosure Project A-list for Climate Change, reinforcing our leadership in environmental stewardship and translating meaningful progress into best-in-class reporting ● Impacted our communities with 81% of our ~22,000 colleagues globally volunteering ~255,000 hours for Xylem Watermark, our corporate social responsibility program ​ ​ Xylem 2026 Proxy Statement | 2 Table of Contents STRATEGY Our overarching strategy is to help customers solve the world’s greatest water challenges with innovative products, services and solutions to deliver sustainable economic, social and environmental benefits.

2025 performance highlights / reported Evoqua synergy achievement · Dépôt 30/03/2026

AND SUBSIDIARIES CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) (in millions, except per share data) Three Months Six Months For the periods ended June 30, 2026 2025 2026 2025 Revenue from products $ 1,953 $ 1,911 $ 3,710 $ 3,620 Revenue from services 383 390 751 750 Revenue 2,336 2,301 4,461 4,370 Cost of revenue from products 1,093 1,129 2,150 2,170 Cost of revenue from services 280 280 545 540 Cost of revenue 1,373 1,409 2,695 2,710 Gross profit 963 892 1,766 1,660 Selling, general and administrative expenses 503 503 975 963 Research and development expenses 59 58 115 114 Restructuring and asset impairment charges 11 26 42 47 Operating income 390 305 634 536 Interest expense (7) (9) (11) (17) Other non-operating (expense)/income, net (3) 3 (3) 7 Loss on sale of businesses (16) — (12) (10) Income before taxes 364 299 608 516 Income tax expense (103) (75) (158) (125) Net income $ 261 $ 224 $ 450 $ 391 Net loss attributable to non-controlling interests 2 2 6 4 Net income attributable to Xylem $ 263 $ 226 $ 456 $ 395 Earnings per share: Basic $ 1.11 $ 0.93 $ 1.90 $ 1.62 Diluted $ 1.11 $ 0.93 $ 1.90 $ 1.62 Weighted average number of shares: Basic 236.3 243.4 239.5 243.3 Diluted 236.6 243.9 240.0 243.8 See accompanying notes to condensed consolidated financial statements.

First-half 2026 income statement / revenue and operating income · Dépôt 28/07/2026

The fair value of the restricted share unit awards is determined using the closing price of our common stock on date of grant: Share units (in thousands) Weighted Average Grant Date Fair Value / Share Outstanding at January 1, 2026 506 $ 123.27 Granted 289 127.60 Vested (239) $ 118.75 Forfeited (20) 129.37 Other (4) 123.24 Outstanding at June 30, 2026 532 $ 127.41 Performance Share Unit Grants Performance share units awarded under the long-term incentive plan vest based upon performance by the Company over a three-year period against targets approved by the Leadership Development & Compensation Committee of the Company's Board of Directors prior to the grant date.

Share-based compensation / three-year performance-share vesting · Dépôt 28/07/2026

The performance share units were each awarded at a target of 100% with actual payout for each type of grant contingent upon the achievement of performance targets as follows: •EBITDA performance share units — a third-year adjusted EBITDA performance target •TSR performance share units — a relative TSR performance target •Revenue performance share units — a pre-set third-year revenue target •EPS performance share units — a cumulative three-year EPS performance target The calculated compensation cost for EBITDA, Revenue and EPS performance share units is adjusted based on an estimate of awards ultimately expected to vest and our assessment of the probable outcome of the performance condition.

Share-based compensation / financial and relative-return performance targets · Dépôt 28/07/2026

Pine 787,500 1,575,000 3,150,000 PSU - TSR 3/5/25 7,037 14,074 28,148 2,540,357 PSU - EPS 3/5/25 7,037 14,074 28,148 1,824,976 RSU 3/5/25 14,074 1,824,976 3/5/25 49,392 129.67 1,825,034 William K.

Grants of plan-based awards / actual 2025 CEO equity grants · Dépôt 30/03/2026

Prohibition on Pledging, Hedging and Shorting: Insider Trading Policy prohibits employees and directors from pledging Xylem securities, purchasing financial instruments, or otherwise engaging in transactions that are designed to or have the effect of hedging or offsetting any decrease in the market value of Xylem securities

Executive compensation policies / pledging, hedging and shorting restrictions · Dépôt 30/03/2026

This year’s updates include: · Implementation of a director skills matrix (see page 9) · Consolidated oversight of all cybersecurity and product safety matters with the Board, with the Audit Committee retaining oversight of cybersecurity disclosures in regulatory filings · Engaged a third-party to facilitate the 2025 annual Board assessment Board Matters ​ · All current directors are independent except our Chief Executive Officer (89%) · Independent Board Chair · Overall 2025 Board and committee meeting attendance of 100% · All directors elected annually · Robust director nominee identification and selection process · Board with a mix of experience, skills, qualifications, attributes, perspectives and backgrounds · Balanced mix of new and more experienced directors, with ~33% of the director nominees’ tenure >6 years and ~66% <6 years · 3 fully independent Board committees · Directors may not stand for re-election after age 72 · Board and committee oversight of strategy, risk, cybersecurity, and human capital matters · Board oversight of our sustainability approach, including regular management updates to the Nominating & Governance Committee · Regular executive sessions of only the independent directors of the Board and each committee · Annual Board and committee self-assessments, with facilitation by a third-party advisor for the 2025 assessments · Comprehensive orientation program for new directors Shareholder Matters ​ · Majority voting with a director resignation policy for directors in uncontested elections · Shareholder proxy access right · Regular engagement with shareholders ● Annual “Say-on-Pay” · Shareholders have the right to call special meetings · One class of stock · No poison pill ​ We value the views of our shareholders and believe that fostering positive relationships with our shareholders is critical to our long-term success.

Corporate governance highlights / independence and shareholder rights · Dépôt 30/03/2026

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.

Independent auditor report / effective internal control opinion · Dépôt 25/02/2026

During the second quarter of 2026, the Company received $4 million of refunds and also recognized a $12 million receivable within prepaid and other current assets in the condensed consolidated balance sheets, with a corresponding reduction to cost of revenue from products.

Accounting disclosures / tariff refunds and reduction of product costs · Dépôt 28/07/2026

The transport application had $79 million of organic revenue growth, driven by strength in all of our major geographic regions, led by increased sales volume and price realization in the U.S.

2024 MD&A / transport revenue growth and realized pricing · Dépôt 03/03/2025

The industrial end market had $105 million of organic growth across all major geographic regions, due to strong price realization and increased sales volume in the U.S.

2023 MD&A / industrial organic growth and realized pricing · Dépôt 28/02/2024

The backlog increase was due to strong order intake in the Water Solutions and Services and Applied Water segments, including the securing of a significant contract in Water Solutions and Services during the three months ended June 30, 2026.

MD&A / order intake and significant Water Solutions and Services contract · Dépôt 28/07/2026

Outlook Xylem now forecasts full-year 2026 revenue of approximately $9.2 billion, up approximately 2 percent on a reported basis, versus 2 to 3 percent previously guided, and up approximately 2 to 3 percent on an organic basis, versus 2 to 4 percent previously guided.

July 2026 outlook / reduced revenue growth guidance · Dépôt 28/07/2026

Historique des publications

Historique des publications
VersionMis à jourAvantage concurrentiel
519/10/2026uncertain
419/10/2026uncertain
318/10/2026uncertain
218/10/2026uncertain
118/10/2026Indisponible

Sources

Méthode et limites de l’analyse · Comprendre ce concept